Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Sodium Retention in Liver Cirrhosis
NCT01311167Phase 3Terminated
- Sponsor
- Insel Gruppe
- Start
- Feb 2011
- Primary completion
- Nov 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in hepatorenal syndrome (HRS), sponsored by Insel Gruppe. Started Feb 2011; status: terminated.
02
Drugs
dexamethasone
03
Conditions
hepatorenal syndrome (HRS)
Beyond the preview
Go deeper on NCT01311167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01311167.